01 9Valeant Canada LP
01 32521379
02 32646901
03 32811272
01 9Methylnaltrexone Bromide
01 9Solution
01 62024-04-08
02 32027-08-03
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Brand Name : RELISTOR
Patent Number : 2521379
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Brand Name : RELISTOR
Patent Number : 2521379
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Brand Name : RELISTOR
Patent Number : 2521379
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2013-07-02
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Brand Name : RELISTOR
Patent Number : 2646901
Filing Date : 2007-08-03
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
Brand Name : RELISTOR
Patent Number : 2811272
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Brand Name : RELISTOR
Patent Number : 2646901
Filing Date : 2007-08-03
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
Brand Name : RELISTOR
Patent Number : 2811272
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Brand Name : RELISTOR
Patent Number : 2646901
Filing Date : 2007-08-03
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2027-08-03
Date Granted : 2015-12-22
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
Brand Name : RELISTOR
Patent Number : 2811272
Filing Date : 2004-04-08
Strength per Unit : 20 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2024-04-08
Date Granted : 2016-12-20
